Prolo Pharmaceutical: The controlling shareholder's concerted action completed a 0.60% increase in holdings, costing approximately 120 million yuan.

2026-03-28 19:22:51

Pro Pharmaceutical announced that its controlling shareholder’s concerted actor, Dongyang Hengdian Yushan Sports Leisure Co., Ltd., increased its stake in the company by a total of 6.9272 million shares through centralized bidding from January 13 to March 23, 2026, accounting for 0.60% of the total share capital, at a cost of 120 million yuan. The increase plan has been completed. After the increase, it holds 16.1688 million shares, accounting for 1.40%; the controlling shareholder and concerted actors collectively hold 608 million shares, accounting for 52.49%. Previously, Yushan Sports planned to increase its investment by 60 million to 120 million yuan within six months.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.